Loading…
Reversible mechanofluorochromic properties of phenothiazine-based D-A-D′ aza-N,O-chelated boron difluoride complexes
[Display omitted] Two new phenothiazine-based D-A-D' aza- N,O-Chelated boron difluoride complexes (E)-5-(4-(dimethylamino)phenyl)-3-((10-ethyl-10H-phenothiazin-3-yl)methylene)-2,2-difluoro-2,3-dihydro-1,3,4,2-oxadiazaborol-3-ium-2-uide (DPDFB) and (E)-3-((10-ethyl-10H-phenothiazin-3-yl)methylen...
Saved in:
Published in: | Tetrahedron letters 2021-08, Vol.78, p.153275, Article 153275 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [Display omitted]
Two new phenothiazine-based D-A-D' aza- N,O-Chelated boron difluoride complexes (E)-5-(4-(dimethylamino)phenyl)-3-((10-ethyl-10H-phenothiazin-3-yl)methylene)-2,2-difluoro-2,3-dihydro-1,3,4,2-oxadiazaborol-3-ium-2-uide (DPDFB) and (E)-3-((10-ethyl-10H-phenothiazin-3-yl)methylene)-2,2-difluoro-5-phenyl-2,3-dihydro-1,3,4,2-oxadiazaborol-3-ium-2-uide (PDDFB) were designed and synthesized. The two BF2 chelating donor–acceptor type aza-N,O-chelated five-membered-ring organoboron complexes displayed large Stokes shifts and remarkable solvatofluorochromism in solutions, as well as good thermal stability in the solid state. Strikingly, the attachment of N,N-dimethyl groups to the terminal benzene ring unit induced significant reversible mechanofluorochromic (MFC) properties (with emission wavelength changes from 617 nm to 660 nm). And the MFC mechanism was ascribed to the phase transformation between crystalline and amorphous state, which was revealed by powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC) and field emission scanning electron microscopy (FESEM) analyses. The introduction of the N,N-dimethyl group demonstrated in this work would be of great help in understanding and designing new MFC materials. |
---|---|
ISSN: | 0040-4039 1873-3581 |
DOI: | 10.1016/j.tetlet.2021.153275 |